Capricor Therapeutics (CAPR) Amortization of Deferred Charges (2013 - 2014)

Capricor Therapeutics (CAPR) recorded quarterly Amortization of Deferred Charges of -$1.0 million in Q4 2014, little changed quarter-over-quarter from -$1.0 million in Q3 2014.

Capricor Therapeutics (CAPR) Amortization of Deferred Charges (2013 - 2014) Analysis & Trends

Capricor Therapeutics' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$1.0 million for Q4 2014.

  • In Q4 2014, Amortization of Deferred Charges changed N/A year-over-year to -$1.0 million; the TTM figure through Dec 2014 stood at $8.3 million (changed N/A YoY), while the FY2014 annual figure was $8.3 million, changed N/A from the prior year.
  • Amortization of Deferred Charges was -$1.0 million for Q4 2014 at Capricor Therapeutics, roughly flat from -$1.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $11.5 million in Q1 2014 to a low of -$1.0 million in Q2 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Capricor Therapeutics 1.53 Bn 1.26 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2014 -1.04 Mn
Dec 31, 2014 -1.04 Mn
Sep 30, 2014 -1.04 Mn
Sep 30, 2014 -1.04 Mn
Jun 30, 2014 -1.04 Mn
Jun 30, 2014 -1.04 Mn
Mar 31, 2014 11.46 Mn
Mar 31, 2014 11.46 Mn
Jun 30, 2013 -3,711.00
Jun 30, 2013 -3,711.00
Mar 31, 2013 3,711.00
Mar 31, 2013 3,711.00